The abstract is read at the publisher; the summary is JClub's.
In 240 healthy term infants in the Philippines, a synbiotic formula (SynF) achieved near-universal Bifidobacterium infantis colonization and lower inflammation versus a control formula over 6 months.
- Why it matters: Formula feeding is linked to different gut microbiota and immune development than breastfeeding, and the trial tests whether adding HMOs plus fermenting microbes can restore healthier immune–microbiome balance.
- What they did: In a randomized controlled trial, infants received SynF containing seven HMOs, bovine milk oligosaccharides, and B. infantis LMG11588 or CtrlF for 6 months, with immune and infection outcomes measured alongside microbiome colonization.
- The result: SynF supported non-inferior growth, increased secretory IgA, reduced intestinal and systemic inflammation markers, slowed immune cell maturation, and reduced upper respiratory tract infections during the first 6 months.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.